翻訳と辞書 |
NXL103
NXL103 (formerly XRP 2868) is an experimental drug candidate under development by Novexel. It is an oral streptogramin antibiotic that has potent ''in vitro'' activity against certain Gram positive bacteria including methicillin resistant ''Staphylococcus aureus'' (MRSA) as well as the important respiratory pathogens including penicillin-, macrolide- and quinolone-resistant strains.〔(Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia ), drugs.com〕 It is a combination of linopristin and flopristin.〔(NXL103 ) at Novexel.com〕 ==Clinical trials== Positive results have been reported from a phase II trial comparing it with amoxicillin.〔 Another phase II trial will be run in 2010 comparing it with linezolid for treatment of acute bacterial skin and skin structure infections (ABSSSI).〔(Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) ), clinicaltrials.gov〕
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「NXL103」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|